Pfizer & Moderna have BIVALENT COVID-19 booster available now.
The approved boosters are considered bivalent vaccines. That means they contain the mRNA sequence for the spike protein of two strains of SARS-CoV-2: the original strain and one common to the current predominant subvariants of Omicron, BA.4 and BA.5. Be sure to visit our COVID-19 Vax Page for additional bivalent clinics.
December 9, 2022:
CDC expanded the use of updated (bivalent) COVID-19 vaccines for children ages 6 months through 5 years. Children ages 6 months through 5 years who previously completed a Moderna primary series are eligible to receive a Moderna bivalent booster 2 months after their final primary series dose. Children ages 6 months through 4 years who are currently completing a Pfizer primary series will receive a Pfizer bivalent vaccine as their third primary dose.
October 21, 2022:
The Pfizer-BioNTech bivalent booster emergency use authorization that includes people 12 years and older has been expanded to include children ages 5-11 years.
The Moderna bivalent booster authorization for those 18 and older has been expanded to include children and adolescents ages 6-17 years.
October 12, 2022:
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. The Moderna COVID-19 Vaccine, Bivalent is authorized for administration at least two months following completion of primary or booster vaccination in children down to six years of age. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent is authorized for administration at least two months following completion of primary or booster vaccination in children down to five years of age.
January's Health Observances highlight important health issues Nationally. We're raising awareness about Healthy Living into 2023 that impact our communities in Essex County. Be sure to check our Facebook page for all Health Observance messages.